4Life Transfer Factor™ - Latest News

<html> <head> <style>  </style> <base target="_self"> <a name="top"> <meta http-equiv="Content-Language" content="en-us"> <meta name="keywords" content="Tranfer Factor, Transfer Factor Plus Advanced, Transfer Factor Advanced, RioVida, Transfer Factor Classic, Transfer Factor Chewables, Transfer Factor for Kids."> <meta name="description" content="4Life® Transfer Factor™ Now Approved By the Health Ministry of Russia for use in Hospitals and Clinics! "> <meta name="GENERATOR" content="Microsoft FrontPage 6.0"> <meta name="ProgId" content="FrontPage.Editor.Document"> <meta http-equiv="Content-Type" content="text/html; charset=windows-1252"> <link rel="File-List" href="TF_russiahospappr_files/filelist.xml"> <title>4Life® Transfer Factor™ - Latest News</title> </head> <body> </a> <p style="margin:0in;margin-bottom:.0001pt" align="justify"> <img border="0" src="newsflash.gif"></p> <p style="margin:0in;margin-bottom:.0001pt" align="justify">  </p> <p style="margin:0in;margin-bottom:.0001pt" align="justify"> <img border="0" src="OlympicAlthletesCert.jpg" width="250" height="349" align="left" hspace="10"></p> <table id="table2" style="BORDER-COLLAPSE: collapse" cellPadding="0" width="65%" border="0"> <tr> <td> <p align="justify"> <b><font color="#FF0000" size="4"> <span class="mainTitle"> <span id="ctl00_MainContentPlaceHolder_lblMainTitle"> <a target="_blank" href="http://onlineshop.my4life.com/NewsStand/dns_headlineNewsDetail.aspx?id=144"> <font color="#FF0000">4Life Transfer Factor<font face="Times New Roman">®</font> Products Approved for Use by Olympic Athletes</font></a></span></span></font></b></p> <p align="justify"> <font face="Arial" size="2" color="#000000"> <b>Salt Lake City, Utah (December 4, 2007)</b> As first reported by 4Life Chief Scientific Officer Calvin McCausland, Ph.D., in Direct Selling News, 4Life received documentation from the Federal Anti-Doping Center in Moscow, Russia, that admits 4Life Transfer Factor for use by Olympians in practice, training, and competition. Approval was obtained after volunteers consumed 4Life Transfer Factor products and their bodily fluids were analyzed in accordance with doping control procedures that employ modern methods of gas chromatography and mass-spectrometry in compliance with the World Anti-Doping Agency in Montreal, Canada.<br> <br> “We are very pleased by this approval,” commented President of Eurasia Emma Oganova, M.D., Ph.D. “4Life Transfer Factor continues to define the cutting-edge of immune system science.”<br> <br> 4Life Founder and Chief Executive Officer David Lisonbee launched 4Life Research in 1998 with a commitment to the highest scientific standards. Ongoing research and development of Transfer Factor technology has fueled 4Life’s constant growth and maximized every distributor’s ability to grow a successful independent business.<br> <br> “Arguably, this kind of marketplace positioning and high level product messaging simply isn’t possible without the involvement of a professional research and development team,” added McCausland.<br> <br> “I am pleased with our continued evolution in the supplement industry,” stated Executive Vice President Bruce Redd. “The quality work of our Research and Development department is certain to keep 4Life on the leading edge of science and success for years to come.”<br> <br> 4Life, the leader in the development, production, and distribution of Transfer Factor support products, continues to post growth in more than 40 countries around the world.</font></td> </tr> </table> <p style="margin:0in;margin-bottom:.0001pt" align="justify">  </p> <p style="margin:0in;margin-bottom:.0001pt" align="justify">  </p> <p style="margin:0in;margin-bottom:.0001pt" align="justify"> <img border="0" src="PDR2008.jpg" width="247" height="334" align="left" hspace="10"></p> <table id="table1" style="BORDER-COLLAPSE: collapse" cellPadding="0" width="65%" border="0"> <tr> <td> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="left"> <span style="font-weight: 700; font-style:italic"> <strong> <a target="_blank" href="http://onlineshop.my4life.com/NewsStand.aspx?pmode=9&iframe=http://media.4life.com/us/digitalnewsstand/headlinenews/html/PDR_1007.html&width=510&height=760"> <font color="#FF0000" face="Arial" size="3">4Life Transfer Factor® Products Included in 2008 Physicians’ Desk Reference</font></a></strong></span></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="left">  </p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="justify"> <font size="2" face="Arial"><b>Salt Lake City, Utah (October 29, 2007)</b> 4Life Research™ announced today that 4Life Transfer Factor Products will be listed in the 2008 Physicians’ Desk Reference: For Nonprescription Drugs, Dietary Supplements, and Herbs(PDR). </font></p> <p align="justify"><font size="2" face="Arial">“We are thrilled once again to be part of this prestigious and popular publication,” stated Director of Product Development Chad Renshaw. “The PDR is yet another step in educating the world about 4Life Transfer Factor and its far-reaching health benefits.”</font></p> <p align="justify"><font size="2" face="Arial">The 2008 edition of the PDR provides an explanation of the recently announced 4Life Transfer Factor® and 4Life Transfer Factor Plus® Tri-Factor™ Formulas, and includes a listing of the 4Life Transfer Factor family products. This professional listing gives 4Life Transfer Factor an additional boost in the scientific community, and helps strengthen every distributor’s position as an exclusive leader in the distribution of 4Life Transfer Factor products. </font></p> <p align="justify"><font size="2" face="Arial">Director of Health Information Services Brent Vaughan commented, “Our 2008 listing provides 4Life Distributors with an excellent resource when presenting our products to potential prospects. It is also a great reference to have in terms of added credibility, as the PDR is a well-respected publication in the medical community.”</font></p> <p align="justify"><font size="2" face="Arial">4Life, the leader in the development, production, and distribution of Transfer Factor support products, continues to post growth in more than 40 countries around the world. </font></p></td> </tr> </table> <p style="margin:0in;margin-bottom:.0001pt" align="justify">  </p> <p style="MARGIN-TOP: 0in; MARGIN-BOTTOM: 0px" align="justify"> <i><strong> <a name="4Life_Research_Announces_New_Discovery" target="_blank" href="http://onlineshop.my4life.com/NewsStand.aspx?pmode=9&iframe=us/digitalnewsstand/headlinenews/html/TF3_09707.html&width=510&height=1000"> <font color="#FF0000" face="Arial">4Life Research Announces New Discovery</font></a><a target="_blank" href="http://onlineshop.my4life.com/NewsStand.aspx?pmode=9&iframe=us/digitalnewsstand/headlinenews/html/TF3_09707.html&width=510&height=1000"><font color="#FF0000" face="Arial" size="2"> </font></a></strong></i></p> <p align="justify"><font size="2" face="Arial"><b> <img border="0" src="newTriFactorProducts.jpg" width="513" height="221"></b></font></p> <p align="justify"><font size="2" face="Arial"><b> September 21, 2007</b> (Salt Lake City, Utah) 4Life Research™, the world leader in Transfer Factor science and immune system support development, announced today the discovery of immune activity in a weight range of molecules significantly smaller than transfer factors. </font></p> <p align="justify"><font size="2" face="Arial">Transfer factors are molecules in a weight class between 3,500 - 12,000 daltons that help the immune system recognize, respond to, and remember outside threats. Although scientists have known that smaller molecules than transfer factors existed within cow colostrum, their significance in terms of immune activity has been unknown until now. </font></p> <p align="justify"><font size="2" face="Arial">In 2005, 4Life Chief Executive Officer David Lisonbee and the Research and Development department began studying these low weight molecules. After two years of research, 4Life clinical findings now indicate that molecules in a weight range between 250 — 3,000 daltons play important regulatory roles in the immune system. </font></p> <p align="justify"><font size="2" face="Arial"> <span style="background-color: #FFFF00">4Life extracted and concentrated these <i><b>nanofraction molecules</b></i> from cow colostrum for their proprietary <b><i>NanoFactor™ extract</i></b>, combining <i><b>NanoFactor</b></i> with their exclusive <i><b>Transfer Factor E-XF™ extract</b></i> of transfer factors from cow colostrum and chicken egg yolks to produce <i><b>4Life Transfer Factor® Tri-Factor™ Formula</b></i>, the most comprehensive approach to immune system support available today. </span> </font></p> <p align="justify"><font size="2" face="Arial">"I don't know of another company in our category," said 4Life Chief Scientific Officer Calvin McCausland, Ph.D. "In 2004, we were the first company to combine transfer factors from cow colostrum and chicken egg yolks. In 2005, we introduced RioVida®, the world's only transfer factor beverage. Now, the discovery of new immune activity in nanofractions. When it comes to scientific innovation, there's simply no comparison to 4Life." </font></p> <p align="justify"><font size="2" face="Arial">4Life Transfer Factor, Transfer Factor Plus®, and RioVida are now fortified with the new Tri-Factor Formula. "We're taking Tri-Factor Formula to the world because no other product represents such a unique and indispensable opportunity for a quality life," remarked 4Life President Steve Tew.</font></p> <p align="justify"><font size="2" face="Arial">David Lisonbee: "At the end of the day, our distributors can rest assured that 4Life will stay a good pace ahead of the curve in the areas of science, service, and success." </font></p> <p align="justify"><font size="2" face="Arial">4Life, global leader in the development, production, and distribution of Transfer Factor immune support products, continues to post growth in more than 40 countries around the world.</font></p> <p style="margin:0in;margin-bottom:.0001pt" align="justify"> <span style="letter-spacing: -1"><a name="top"><b> <span style="font-size:13.5pt;font-family:Arial;color:blue">4Life<sup>®</sup> Transfer Factor™ Now Approved By the Health Ministry of </span></b></a><b> <span style="font-size:13.5pt;font-family:Arial; color:blue">Russia</span><span style="font-size:13.5pt;font-family:Arial; color:blue"> for use in Hospitals and Clinics!</span></b></span></p> <p style="margin:0in;margin-bottom:.0001pt" align="justify">  </p> <p style="margin:0in;margin-bottom:.0001pt" align="justify"><b><i> <span style="font-family:Arial;color:red">First Ever Dietary Supplement to be Approved for Use by Doctors and Hospitals in Russia</span></i></b></p> <p style="margin-top:0in" align="justify"> <span style="font-size:10.0pt;font-family:Arial;color:black">SANDY, UT (October 1, 2004) - In an unprecedented announcement in the history of network marketing, 4Life announced today that 4Life Transfer Factor products as immune modulators have been approved for use in hospitals and clinics in the Russian Federation. The results of ten separate clinical trials and two experimental studies on 4Life Transfer Factor products were combined in a Methodological Document that was approved by the Ministry of Health, which now allows doctors to recommend 4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their patients. </span></p> <p style="margin-top: 0in; margin-bottom: 0" align="justify"><b> <span style="font-family: Arial; color: red; font-style: italic">First Dietary Supplement Approved for Use by Doctors and Hospitals in Russia</span></b></p> <p style="margin-top: 0in; margin-bottom: 0" align="